Finally, we tested if VPS39 expression in human skeletal muscle biopsies correlates with measures of insulin sensitivity analyzed in vivo with a euglycemic hyperinsulinemic clamp, and whether the expression is reduced in biopsies from individuals with T2D versus control individuals in a cohort previously described4. The gene discussed is VPS39; the disease is type 2 diabetes mellitus.